GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NSE:DRREDDY) » Definitions » Investments And Advances

Dr Reddy's Laboratories (NSE:DRREDDY) Investments And Advances : ₹5,979 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dr Reddy's Laboratories Investments And Advances?

Dr Reddy's Laboratories's Investments And Advances for the quarter that ended in Sep. 2024 was ₹5,979 Mil.

Dr Reddy's Laboratories's quarterly Investments And Advances declined from Mar. 2024 (₹5,255 Mil) to Jun. 2024 (₹5,209 Mil) but then increased from Jun. 2024 (₹5,209 Mil) to Sep. 2024 (₹5,979 Mil).

Dr Reddy's Laboratories's annual Investments And Advances declined from Mar. 2022 (₹7,986 Mil) to Mar. 2023 (₹5,362 Mil) and declined from Mar. 2023 (₹5,362 Mil) to Mar. 2024 (₹5,255 Mil).

Dr Reddy's Laboratories Investments And Advances Historical Data

The historical data trend for Dr Reddy's Laboratories's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Investments And Advances Chart

Dr Reddy's Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,091.00 8,333.00 7,986.00 5,362.00 5,255.00

Dr Reddy's Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,924.00 8,333.00 5,255.00 5,209.00 5,979.00

Dr Reddy's Laboratories Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Dr Reddy's Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NSE:DRREDDY) » Definitions » Investments And Advances
Comparable Companies
BOM:543904 BOM:532321 NSE:TORNTPHARM BOM:500257 NSE:AUROPHARMA NSE:ALKEM NSE:DIVISLAB BOM:532296 BOM:524494 BOM:532331 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA VTRS HKSE:03692
Traded in Other Exchanges
RDY:USA 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Website
https://www.drreddys.com
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines